OSR Health addresses Nasdaq delisting and outlines near-term plans.
Following a Nasdaq panel decision to delist, OSR Health remains focused on regaining compliance by November 6. The company confirmed its VXM01 funding mechanism and commitment to existing shareholder programs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed